Guggenheim raises Everpure target to $215 from $150, keeps Buy

On Oct. 12, analyst Howard Ma raised Guggenheim’s target to $215 from $150 and maintained Buy. The note cited CFO Tarek Robbiati and VP of IR Paul Ziots’ investor meetings, Everpure’s FY28 outlook of 39–45% growth and 24–26% operating margin, and contracted hyperscaler shipments into CY28/FY29.